Cargando…
Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study
BACKGROUND: Intravenous glycerol treatment, usually administered in the form of a 5% fructose solution, can be used to reduce intracranial pressure. The administered fructose theoretically influences blood lactate levels, although little is known regarding whether intravenous glycerol treatment caus...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114507/ https://www.ncbi.nlm.nih.gov/pubmed/30181880 http://dx.doi.org/10.1186/s40560-018-0323-7 |
_version_ | 1783351205585485824 |
---|---|
author | Katayama, Shinshu Tonai, Ken Goto, Yuya Koyama, Kansuke Koinuma, Toshitaka Shima, Jun Wada, Masahiko Nunomiya, Shin |
author_facet | Katayama, Shinshu Tonai, Ken Goto, Yuya Koyama, Kansuke Koinuma, Toshitaka Shima, Jun Wada, Masahiko Nunomiya, Shin |
author_sort | Katayama, Shinshu |
collection | PubMed |
description | BACKGROUND: Intravenous glycerol treatment, usually administered in the form of a 5% fructose solution, can be used to reduce intracranial pressure. The administered fructose theoretically influences blood lactate levels, although little is known regarding whether intravenous glycerol treatment causes transient hyperlactatemia. This study aimed to evaluate blood lactate levels in patients who received intravenous glycerol or mannitol. METHODS: This single-center prospective observational study was performed at a 14-bed general intensive care unit between August 2016 and January 2018. Patients were excluded if they were < 20 years old or had pre-existing hyperlactatemia (blood lactate > 2.0 mmol/L). The included patients received intravenous glycerol or mannitol to reduce intracranial pressure and provided blood samples for lactate testing before and after the drug infusion (before the infusion and after 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, and 150 min). RESULTS: Among the 33 included patients, 13 patients received 200 mL of glycerol over 30 min, 13 patients received 200 mL of glycerol over 60 min, and 7 patients received 300 mL of mannitol over 60 min. Both groups of patients who received glycerol had significantly higher lactate levels than the mannitol group (2.8 mmol/L vs. 2.2 mmol/L vs. 1.6 mmol/L, P < 0.0001), with the magnitude of the increase in lactate levels corresponding to the glycerol infusion time. There were no significant inter-group differences in cardiac index, stroke volume, or stroke volume variation. In the group that received the 30-min glycerol infusion, blood lactate levels did not return to the normal range until after 120 min. CONCLUSIONS: Intravenous administration of glycerol leads to higher blood lactate levels that persist for up to 120 min. Although hyperlactatemia is an essential indicator of sepsis and/or impaired tissue perfusion, physicians should be aware of this phenomenon when assessing the blood lactate levels. |
format | Online Article Text |
id | pubmed-6114507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61145072018-09-04 Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study Katayama, Shinshu Tonai, Ken Goto, Yuya Koyama, Kansuke Koinuma, Toshitaka Shima, Jun Wada, Masahiko Nunomiya, Shin J Intensive Care Research BACKGROUND: Intravenous glycerol treatment, usually administered in the form of a 5% fructose solution, can be used to reduce intracranial pressure. The administered fructose theoretically influences blood lactate levels, although little is known regarding whether intravenous glycerol treatment causes transient hyperlactatemia. This study aimed to evaluate blood lactate levels in patients who received intravenous glycerol or mannitol. METHODS: This single-center prospective observational study was performed at a 14-bed general intensive care unit between August 2016 and January 2018. Patients were excluded if they were < 20 years old or had pre-existing hyperlactatemia (blood lactate > 2.0 mmol/L). The included patients received intravenous glycerol or mannitol to reduce intracranial pressure and provided blood samples for lactate testing before and after the drug infusion (before the infusion and after 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, and 150 min). RESULTS: Among the 33 included patients, 13 patients received 200 mL of glycerol over 30 min, 13 patients received 200 mL of glycerol over 60 min, and 7 patients received 300 mL of mannitol over 60 min. Both groups of patients who received glycerol had significantly higher lactate levels than the mannitol group (2.8 mmol/L vs. 2.2 mmol/L vs. 1.6 mmol/L, P < 0.0001), with the magnitude of the increase in lactate levels corresponding to the glycerol infusion time. There were no significant inter-group differences in cardiac index, stroke volume, or stroke volume variation. In the group that received the 30-min glycerol infusion, blood lactate levels did not return to the normal range until after 120 min. CONCLUSIONS: Intravenous administration of glycerol leads to higher blood lactate levels that persist for up to 120 min. Although hyperlactatemia is an essential indicator of sepsis and/or impaired tissue perfusion, physicians should be aware of this phenomenon when assessing the blood lactate levels. BioMed Central 2018-08-28 /pmc/articles/PMC6114507/ /pubmed/30181880 http://dx.doi.org/10.1186/s40560-018-0323-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Katayama, Shinshu Tonai, Ken Goto, Yuya Koyama, Kansuke Koinuma, Toshitaka Shima, Jun Wada, Masahiko Nunomiya, Shin Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study |
title | Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study |
title_full | Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study |
title_fullStr | Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study |
title_full_unstemmed | Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study |
title_short | Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study |
title_sort | transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114507/ https://www.ncbi.nlm.nih.gov/pubmed/30181880 http://dx.doi.org/10.1186/s40560-018-0323-7 |
work_keys_str_mv | AT katayamashinshu transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy AT tonaiken transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy AT gotoyuya transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy AT koyamakansuke transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy AT koinumatoshitaka transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy AT shimajun transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy AT wadamasahiko transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy AT nunomiyashin transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy |